Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder

Exclusion Criteria

• •Patient is at immediate risk for suicidal behavior
• •Patient with psychotic features, catatonic features, seasonal pattern or postpartum onset
• •Patients with a current depressive episode secondary to a general medical disorder
• •Patients with a lifetime history or presence of bipolar disorder, psychotic disorder, panic disorder and antisocial personality disorder
• •Patients with severe or unstable concomitant medical conditions
• •Pregnant, breastfeeding, or likely to become pregnant during the study
• •Treated with escitalopram within 6 months before the study, or who have had an adverse reaction to escitalopram
• •The investigator will evaluate whether there are other reasons why a patient may not participate.